| 1 |
Stanulla M, Cario G, Meissner B, et al. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia:a perspective from the BFM Study Group[J]. Blood Cells Mol Dis, 2007, 39(2):160-163.
|
| 2 |
吴敏媛，李志光，李志刚．儿童急性淋巴细胞性白血病治疗策略的思考[J]．中华儿科杂志，2010，48(3)：161-165.
|
| 3 |
Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation[J]. N Engl J Med, 2009, 360(23):2730-2741.
|
| 4 |
Chauvenet AR, Martin PL, Devidas M, et al. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group study P9201[J]. Blood, 2007, 110(11):1105-1111.
|
| 5 |
Matloub Y, Lindemulder S, Gaynon PS, et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukaemia, reported by the Children's Oncology Group[J]. Blood, 2006, 108(10):1165-1173.
|
| 6 |
Campana D. Minimal residual disease monitoring in childhood acute lymphoblastic leukemia[J]. Curr Opin Hematol, 2012, 19(4):313-318.
|
| 7 |
Pui CH, Mullighan CG, Evans WE, et al. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there？[J]. Blood, 2012, 120(6):1165-1174.
|
| 8 |
VHJ van der Velden VHJ, van Dongen JJM. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR[J]. Method Mol Biol, 2009, 538(2):115-150.
|
| 9 |
李志刚，崔蕾，高超，等．以Ig/TCR基因重排为分子标志的儿童急性淋巴细胞性白血病微小残留病检测的技术方案[J]．中华儿科杂志，2011，49(3)：165-169.
|
| 10 |
张瑞东，刘怡，巩文玉，等．儿童急性淋巴细胞白血病微小残留病技术方案[J]．中华儿科杂志，2011，49(8)：596-598.
|
| 11 |
Brüggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008[J]. Leukemia, 2010, 24(3):521-535.
|
| 12 |
Lei Cui, Zhigang Li, Minyuan Wu, et al. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia[J]. Leukemia Res, 2010, 34(10):1314-1319.
|
| 13 |
Zeller B, Tamnes CK, Kanellopoulos A, et al. Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia[J]. J Clin Oncol, 2013, 31(17):2078-2085.
|
| 14 |
Krull KR, Brinkman TM, Li C, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study[J]. J Clin Oncol, 2013, 31(35):4407-4415.
|
| 15 |
Armstrong GT, Reddick WE, Petersen RC, et al. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy[J]. J Natl Cancer Inst, 2013, 105(12):899-907.
|
| 16 |
Locatelli F, Schrappe M, Bernardo ME, et al. How I treat relapsed childhood acute lymphoblastic leukemia[J]. Blood, 2012, 120(14):2807-2816.
|
| 17 |
Ramsey LB, Bruun GH, Yang W, et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition[J]. Genome Res, 2012, 22(1):1-8.
|
| 18 |
Levinsen M, Rotevatn E∅, Rosth∅j S, et al. Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer[J]. Pediatr Blood Cancer, 2014, 61(5):797-802.
|
| 19 |
Liu SG, Li ZG, Cui L, et al. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population[J]. Leukemia Lymphoma, 2011, 52(6):1030-1040.
|
| 20 |
Liu SG, Gao C, Zhang RD, et al. FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia[J]. Cancer Cell Int, 2013, 13(1):107-111.
|
| 21 |
Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update[J]. J Clin Oncol, 2011, 29(5):551-565.
|
| 22 |
Rives S, Camós M, Estella J, et al. Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005[J]. Br J Hematol, 2013, 162(3):413-427.
|